1.Latanoprost in the management of angle closure glaucoma
Tocyap Mary Lillian D ; Lee Maria Regina A ; Flores John Vincent d.G ; Aquino Mario V
Philippine Journal of Ophthalmology 2002;27(1):21-26
Objective: To investigate the effect of latanoprost in IOP after laser iridectomy or filtering surgery Methodology: Patients of chronic angle closure glaucoma post laser iridectomy or filtering surgery were given latanoprost 0.005 percent eye drop in the evening for 2-6 weeks after a washout period ranging from 5 days - 28 days. IOP was measured at 9:00 a. m., 1:00 p.m. and 5: 00 p.m. per patient using a calibrated goldmann applanation tonometer Results: 29 patients were enrolled in study. There was a significant reduction in IOP among these patients Conclusion: Latanoprost 0.005 percent provides a significant reduction in IOP among patients with residual angle closure after laser iridectomy or filtering surgery. (Author)
Human
;
Male
;
Female
;
LATANOPROST
;
INTRAOCULAR PRESSURE/DRUG EFFECTS
;
GLAUCOMA, ANGLE-CLOSURE
;
GLAUCOMA, ANGLE-CLOSURE/DRUG THERAPY
;
HUMANS
;
MALE
;
FEMALE
;